Bioactive proteins and peptides from soybeans

Recent Patents on Food, Nutrition and Agriculture

Volumn 7, Issue 2, 2015, Pages 100-107

  Agyei, Dominic ^a  

^a DEAKIN UNIVERSITY   (Australia)

Author keywords

Bioactive proteins and peptides; Biological activities; FOSHU; Functional food; Soybeans

Indexed keywords

ANTIINFECTIVE AGENT; ANTIOXIDANT; IMMUNOLOGIC FACTOR; PEPTIDE; PROTEIN HYDROLYSATE; PROTEIN INTAKE; SOYBEAN PROTEIN;

CHEMISTRY; FUNCTIONAL FOOD; HUMAN; PATENT; PHARMACOLOGY; PROTEIN INTAKE; SOYBEAN;

ANTI-INFECTIVE AGENTS; ANTIOXIDANTS; DIETARY PROTEINS; FUNCTIONAL FOOD; HUMANS; IMMUNOLOGIC FACTORS; PATENTS AS TOPIC; PEPTIDES; PROTEIN HYDROLYSATES; SOYBEAN PROTEINS; SOYBEANS;

EID: 84945294732     PISSN: 22127984     EISSN: 18761429     Source Type: Journal    
DOI: 10.2174/2212798407666150629134141     Document Type: Article

References (79)

1. Shurtleff W, Aoyagi A. History of soybeans and soyfoods in Southeast Asia (13th Century To 2010): Extensively Annotated Bibliography and Sourcebook: Soyinfo Center 2010.
2. Singh P, Kumar R, Sabapathy S.N., Bawa AS. Functional and edible uses of soy protein products. Comprehensive Rev Food Sci Food Saf 2008; 7: 14-28.
3. Hettiarachchy NS, Kalapathy U. Functional properties of soy proteins. Functional properties of proteins and lipids. ACS Symposium Series. Am Chem Soc 1998; 708: 80-95.
4. Hughes GJ, Ryan DJ, Mukherjea R, Schasteen CS Protein digestibility-corrected amino acid scores (PDCAAS) for soy protein isolates and concentrate: Criteria for evaluation. J Agric Food Chem 2011; 59: 12707-12.
5. Korhonen H, Pihlanto A. Bioactive peptides: Production and functionality. Int Dairy J 2006; 16: 945-60.
6. Gauthier SF, Pouliot Y, Saint-Sauveur D. Immunomodulatory peptides obtained by the enzymatic hydrolysis of whey proteins. Int Dairy J 2006; 16: 1315-23.
7. Singh BP, Vij S, Hati S. Functional significance of bioactive peptides derived from soybean. Peptides 2014; 54: 171-9.
8. Gibbs BF, Zougman A, Masse R., Mulligan C. Production and characterization of bioactive peptides from soy hydrolysate and soy-fermented food. Food Res Int 2004; 37: 123-31.
9. Agyei D, Danquah MK Industrial-scale manufacturing of pharmaceutical-grade bioactive peptides. Biotechnol Adv 2011; 29: 272-7.
10. Vasconcellos FCS, Woiciechowski AL, Soccol V.T., Mantovani D., Soccol CR. Antimicrobial and antioxidant properties of β-conglycinin and glycinin from soy protein isolate. Int J Curr Microbiol Appl Sci 2014; 3: 144-57.
11. Lu J, Zeng Y, Hou W., Zhang S, Li L, Luo X., et al. The soybean peptide aglycin regulates glucose homeostasis in type 2 diabetic mice via IR/IRS1 pathway. J Nutr Biochem 2012; 23: 1449-57.
12. Chen H-M, Muramoto K., Yamauchi F. Structural analysis of antioxidative peptides from soybean.beta.-Conglycinin. J Agric Food Chem 1995; 43: 574-8.
13. Chen H-M, Muramoto K., Yamauchi F, Nokihara K. Antioxidant activity of designed peptides based on the antioxidative peptide isolated from digests of a soybean protein. J Agric Food Chem 1996; 44: 2619-23.
14. Park SY, Lee J-S, Baek H-H, Lee HG. Purification and characterization of antioxidant peptides from soy protein hydrolysate. J Food Biochem 2010; 34: 120-32.
15. Rayaprolu SJ, Hettiarachchy NS, Chen P, Kannan A., Mauromostakos A. Peptides derived from high oleic acid soybean meals inhibit colon, liver and lung cancer cell growth. Food Res Int 2013; 50: 282-8.
16. Odani S, Koide T, Ono T. Amino acid sequence of a soybean (Glycine max) seed polypeptide having a poly(L-aspartic acid) structure. J Biol Chem 1987; 262: 10502-5.
17. Galvez AF, de Lumen BO. A soybean cDNA encoding a chromatin-binding peptide inhibits mitosis of mammalian cells. Nat Biotech 1999; 17: 495-500.
18. Galvez AF, Chen N, Macasieb J., de Lumen BO. Chemopreventive property of a soybean peptide (lunasin) that binds to deacetylated histones and inhibits acetylation. Cancer Res 2001; 61: 7473-8.
19. Kim SE, Kim HH, Kim J.Y., Kang YI, Woo HJ, Lee HJ. Anticancer activity of hydrophobic peptides from soy proteins. BioFactors 2000; 12: 151-5.
20. Shimakage A, Shinbo M, Yamada S. ACE inhibitory substances derived from soy foods. J Biol Macromol 2012; 12: 72-80.
21. Vallabha VS, Tiku PK Antihypertensive peptides derived from soy protein by fermentation. Int J Peptide Res Ther 2014; 20: 161-8.
22. Ohinata K, Agui S, Yoshikawa M. Soymorphins, novel mu opioid peptides derived from soy beta-conglycinin beta-subunit, have anxiolytic activities. Biosci Biotechnol Biochem 2007; 71: 2618-21.
23. Tsuruki T, Takahata K, Yoshikawa M. Anti-alopecia mechanisms of soymetide-4, an immunostimulating peptide derived from soy β-conglycinin. Peptides 2005; 26: 707-11.
24. Tsuruki T, Kishi K, Takahashi M., Tanaka M, Matsukawa T, Yoshikawa M. Soymetide, an immuno stimulating peptide derived from soybean β-conglycinin, is an fMLP agonist. FEBS Letters 2003; 540: 206-10.
25. Cho SJ, Juillerat MA, Lee CH Cholesterol lowering mechanism of soybean protein hydrolysate. J Agric Food Chem 2007; 55: 10599-604.
26. Kim S-K, Wijesekara I. Development and biological activities of marine-derived bioactive peptides: A review. J Functional Food 2010; 2: 1-9.
27. Huang W-Y, Davidge S.T., Wu J. Bioactive natural constituents from food sources - potential use in hypertension prevention and treatment. Crit Rev Food Sci Nutr 2012; 53: 615-30.
28. Saavedra L, Hebert EM, Minahk C, Ferranti P. An overview of "omic" analytical methods applied in bioactive peptide studies. Food Res Int 2013; 54: 925-34.
29. Hancock REW, Sahl H-G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nature Biotechnol 2006; 24: 1551-7.
30. Haslam DW, James WPT. Obesity. Lancet 2005; 366: 1197-209.
31. Hwang JW, Do HJ, Kim O.Y., Chung JH, Lee J-Y, Park YS, et al Fermented soy bean extract suppresses differentiation of 3T3-L1 preadipocytes and facilitates its glucose utilization. J Functional Food 2015; 15: 516-24.
32. Yang H, Kwon D, Kim M., Kang S, Park S. Meju, unsalted soybeans fermented with Bacillus subtilis and Aspergilus oryzae, potentiates insulinotropic actions and improves hepatic insulin sensitivity in diabetic rats. Nutr Metabol 2012; 9: 37.
33. Niiho Y, Yamazaki T, Hosono T., Nakajima Y, Ishizaki M, Kurashige T. Pharmacological studies on small peptide fraction derived from soybean. The effects of small peptide fraction derived from soybean on fatigue, obesity and glycemia in mice. Yakugaku zasshi 1993; 113: 334-42.
34. Dun XP, Wang JH, Chen L, Lu J., Li FF, Zhao YY, et al. Activity of the plant peptide aglycin in mammalian systems. FEBS J 2007; 274: 751-9.
35. Jiang H, Feng J, Du Z., Zhen H, Lin M, Jia S., et al. Oral administration of soybean peptide Vglycin normalizes fasting glucose and restores impaired pancreatic function in Type 2 diabetic Wistar rats. J Nutr Biochem 2014; 25: 954-63.
36. Ramalingam M, Kim SJ Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases. J Neural Transm 2012; 119: 891-910.
37. Devasagayam TP, Tilak JC, Boloor K.K., Sane KS, Ghaskadbi SS, Lele RD. Free radicals and antioxidants in human health: Current status and future prospects. J Assoc Physicians India 2004; 52: 794-804.
38. Yang J-H, Mau J-L, Ko P-T, Huang L-C. Antioxidant properties of fermented soybean broth. Food Chem 2000; 71: 249-54.
39. Wade AM, Tucker HN Antioxidant characteristics of L-histidine 1. J Nutr Biochem 1998; 9: 308-15.
40. Beermann C, Euler M, Herzberg J., Stahl B. Anti-oxidative capacity of enzymatically released peptides from soybean protein isolate. Euro Food Res Technol 2009; 229: 637-44.
41. Sarmadi BH, Ismail A. Antioxidative peptides from food proteins: A review. Peptides 2010; 31: 1949-56.
42. Jiménez-Ruiz E.I., Calderón de la Barca AM, Sotelo-Mundo RR, Arteaga-Mackinney GE, Valenzuela-Melendez M, Peña-Ramos EA. Partial characterization of ultrafiltrated soy protein hydrolysates with antioxidant and free radical scavenging activities. J Food Sci 2013; 78: C1152-C8.
43. Ranamukhaarachchi S, Meissner L, Moresoli C. Production of antioxidant soy protein hydrolysates by sequential ultrafiltration and nanofiltration. J Membrane Sci 2013; 429: 81-7.
44. Roblet C, Amiot J, Lavigne C., Marette A, Lessard M, Jean J., et al. Screening of in vitro bioactivities of a soy protein hydrolysate separated by hollow fiber and spiral-wound ultrafiltration membranes. Food Res Int 2012; 46: 237-49.
45. Wang D, Wang L-J, Zhu F-X, Zhu J-Y, Chen XD, Zou L, et al In vitro and in vivo studies on the antioxidant activities of the aqueous extracts of Douchi (a traditional Chinese salt-fermented soybean food). Food Chem 2008; 107: 1421-8.
46. Hu C-C, Hsiao C-H, Huang S-Y, Fu S-H, Lai C-C, Hong T-M, et al. Antioxidant activity of fermented soybean extract. J Agric Food Chem 2004; 52: 5735-9.
47. Uster A, Ruefenacht U, Ruehlin M., Pless M, Siano M, Haefner M., et al. Influence of a nutritional intervention on dietary intake and quality of life in cancer patients: A randomized controlled trial. Nutrition 2013; 29: 1342-9.
48. Marin CMM, Laviano A, Pichard C. Impact of nutrition on quality of life during cancer. Curr Opin Clin Nutr Metab Care 2007; 10: 480-7.
49. Falciani C, Pini A, Bracci L. Oligo-branched peptides for tumor targeting: From magic bullets to magic forks. Expert Opin Biol Ther 2009; 9: 171-8.
50. Jang A, Jo C, Kang K-S, Lee M. Antimicrobial and human cancer cell cytotoxic effect of synthetic angiotensin-converting enzyme (ACE) inhibitory peptides. Food Chem 2008; 107: 327-36.
51. Eliassen LT, Berge G, Sveinbjornsson B., Svendsen JS, Vorland LH, Rekdal O. Evidence for a direct antitumor mechanism of action of bovine lactoferricin. Anticancer Res 2002; 22: 2703-10.
52. Hsieh C-C, Hernández-Ledesma B, Jeong HJ, Park JH, de Lumen BO. Complementary roles in cancer prevention: Protease inhibitor makes the cancer preventive peptide lunasin bioavailable. PLoS One 2010; 5: e8890.
53. Jeong HJ, Jeong JB, Kim D.S., Park JH, Lee JB, Kweon DH, et al The cancer preventive peptide lunasin from wheat inhibits core histone acetylation. Cancer Lett 2007; 255: 42-8.
54. Lam Y, Galvez A, de Lumen BO. Lunasin" Suppresses E1A-mediated transformation of mammalian cells but does not inhibit growth of immortalized and established cancer cell lines. Nutr Cancer 2003; 47: 88-94.
55. Seber LE, Barnett BW, McConnell E.J., Hume SD, Cai J, Boles K, et al Scalable purification and characterization of the anticancer lunasin peptide from soybean. PLoS One 2012; 7: e35409.
56. Hernandez-Ledesma B., Hsieh CC, de Lumen BO. Antioxidant and anti-inflammatory properties of cancer preventive peptide lunasin in RAW 264.7 macrophages. Biochem Biophys Res Commun 2009; 390: 803-8.
57. Galvez, A.F. Use of soy peptide (lunasin) to lower total and LDL cholesterol levels. EP2061313B1 (2013).
58. Galvez, A.F. Products and methods using soy peptides to lower total and LDL cholesterol levels. WO2008034116A2 (2008).
59. Galvez, A.F. Methods for using soy peptides to inhibit h3 acetylation, reduce expression of hmg-coa reductase and increase ldl receptor and sp1 expression in a mammal. US20100197594A1 (2010).
60. de Lumen, B.O., Galvez, A.F. Soybean protein nutraceuticals. US6391848B1 (2002).
61. Badger TM, Ronis MJ, Simmen R.C., Simmen FA. Soy protein isolate and protection against cancer. J Am Coll Nutr 2005; 24: 146S-9S.
62. James PA, Oparil S, Carter BL 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the eighth joint national committee (jnc 8). JAMA 2014; 311: 507-20.
63. Pagidipati NJ, Gaziano TA Estimating deaths from cardiovascular disease: A review of global methodologies of mortality measurement. Circulation 2013; 127: 749-56.
64. Puchalska P, Concepción GM, Luisa MM. Identification of native angiotensin-I converting enzyme inhibitory peptides in commercial soybean based infant formulas using HPLC-Q-ToF-MS. Food Chem 2014; 157: 62-9.
65. Hernández-Ledesma B., Amigo L, Ramos M., Recio I. Angiotensin converting enzyme inhibitory activity in commercial fermented products. Formation of peptides under simulated gastrointestinal digestion. J Agric Food Chem 2004; 52: 1504-10.
66. De Leo F., Panarese S, Gallerani R., Ceci LR. Angiotensin converting enzyme (ACE) inhibitory peptides: Production and implementation of functional food. Curr Pharm Des 2009; 15: 3622-43.
67. Mallikarjun GKG, Gowda LR, Rao AGA, Prakash V. Angiotensin I-converting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max). J Agric Food Chem 2006; 54: 4568-73.
68. Yoshikawa M, Fujita H, Matoba N., Takenaka Y, Yamamoto T, Yamauchi R., et al. Bioactive peptides derived from food proteins preventing lifestyle-related diseases. BioFactors 2000; 12: 143-6.
69. Shin Z-I, Yu R., Park S-A, Chung DK, Ahn C-W, Nam H-S, et al. His-His-Leu, an angiotensin I converting enzyme inhibitory peptide derived from korean soybean paste, exerts antihypertensive activity in vivo. J Agric Food Chem 2001; 49: 3004-9.
70. Koch G, Wiedemann K, Teschemacher H. Opioid activities of human β-casomorphins. Naunyn-Schmiedeberg's Arch Pharmacol 1985; 331: 351-4.
71. Kaneko K, Iwasaki M, Yoshikawa M., Ohinata K. Orally administered soymorphins, soy-derived opioid peptides, suppress feeding and intestinal transit via gut μ1-receptor coupled to 5-HT1A, D2, and GABAB systems. Am J Physiol - Gastrointestinal Liver Physiol 2010; 299: G799-G805.
72. Yamada Y, Muraki A, Oie M., Kanegawa N, Oda A, Sawashi Y., et al. Soymorphin-5, a soy-derived mu-opioid peptide, decreases glucose and triglyceride levels through activating adiponectin and PPARalpha systems in diabetic KKAy mice. Am J Physiol Endocrinol Metabol 2012; 302: E433-40.
73. Potter SM. Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 1995; 125: 606S-11S.
74. Ruiz RJC, Betancur ADA, Segura CMR. Bioactive vegetable proteins and peptides in lipid-lowering; nutraceutical potential. Nutr Hosp 2014; 29: 776-84.
75. Ferreira Ed S, Silva MA, Demonte A, Neves VA β-Conglycinin (7S) and glycinin (11S) exert a hypocholesterolemic effect comparable to that of fenofibrate in rats fed a high-cholesterol diet. J Functional Food 2010; 2: 275-83.
76. Maruyama N, Maruyama Y, Tsuruki T., Okuda E, Yoshikawa M, Utsumi S. Creation of soybean β-conglycinin β with strong phagocytosis-stimulating activity. Biochim Biophysic Acta - Protein Proteom 2003; 1648: 99-104.
77. Jiang, S.T., Yin, L.J., Tai, H.M. Mineral-peptide chelates. US20130224794A1 (2013).
78. Nakamori, T. Method of producing beers and soybean peptide for producing beers. US20080089977A1 (2008).
79. Rodemann, H.P., Dittmann, K., Güven, N., Mayer, C. Peptide with radio protective effect. US6645934B1 (2003).